Clinical trial
Impact of Parathyroid Hormone (PTH) on Osseous Cavity
NCT00277706 · University of Michigan, Other · Completed
Key facts
| NCT number | NCT00277706 |
|---|---|
| Title | Impact of Parathyroid Hormone (PTH) on Osseous Cavity |
| Official title | Impact of Parathyroid Hormone (1-34) on Osseous Regeneration in the Oral Cavity |
| Lead sponsor | University of Michigan, Other |
| Collaborators | Eli Lilly and Company Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Bone Loss, Periodontitis |
| Intervention type | Dietary Supplement, Drug, Procedure |
| Interventions | Periodontal surgery, FORTEO, Placebo, Vitamin D and Calcium |
| Enrollment | 40 |
| Start date | Aug 1, 2004 |
| Primary completion | Jul 1, 2009 |
| Completion | Jul 1, 2009 |
| First posted | Jan 16, 2006 |
| Last update posted | Oct 7, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: